Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Avivo Biomedical Logo
Avivo Biomedical Growth Score
54
CB Rank
43448
Heat Score
86
Avivo Biomedical operates as a preclinical-stage company.
Founded
obfuscation
PrivateSeed Vancouver, British Columbia, Canada1-10 avivobio.com/
Biotechnology
Medical
Overview

Avivo Biomedical
Total Funding
obfuscation
Growth Score
54
Heat Score
86

Total Funding
obfuscation
Seed raised
obfuscation
Growth Score54
1 pts
in past quarter
Heat Score 86
13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Avivo Biomedical

CB Rank
43448
Avivo Biomedical operates as a preclinical-stage company.
Founded
obfuscation
PrivateSeed Vancouver, British Columbia, Canada1-10 avivobio.com/
Biotechnology
Medical

Funding Rounds

Seed
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Pre-Seed
OBF
in
obfuscation

Key People

Details

Legal Name ABOzymes Biomedical Inc.
Also Known As ABOzymes, ABOzymes Biomedical
Operating Status Active
Company Type For Profit
Founders  Geoff Houlton, John Barclay
About the Company
Avivo Biomedical operates as a preclinical-stage company, has identified enzymes that convert the cell surface antigens that determine a person’s blood group to group O, the universal donor type.
Predictions & Insights

Products & Services

Ex Vivo Enzymatic Blood Type Conversion
A process that enzymatically converts donor blood or organs from one blood type to a universal blood type to increase compatibility for transfusions and transplants.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Avivo Biomedical Logo
Seed Round - Avivo Biomedical
—
obfuscation
— Seed
obfuscation
Seed Round - Avivo Biomedical Logo
Seed Round - Avivo Biomedical
—
obfuscation
— Seed
obfuscation
Seed Round - Avivo Biomedical Logo
Seed Round - Avivo Biomedical
—
obfuscation
— Seed
obfuscation
Seed Round - Avivo Biomedical Logo
Seed Round - Avivo Biomedical
—
obfuscation
— Seed
obfuscation
Seed Round - Avivo Biomedical Logo
Seed Round - Avivo Biomedical
—
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Avivo Biomedical Logo
Seed Round - Avivo Biomedical
—
obfuscation
— Seed
obfuscation
Seed Round - Avivo Biomedical Logo
Seed Round - Avivo Biomedical
—
obfuscation
— Seed
obfuscation
Seed Round - Avivo Biomedical Logo
Seed Round - Avivo Biomedical
—
obfuscation
— Seed
obfuscation
Seed Round - Avivo Biomedical Logo
Seed Round - Avivo Biomedical
—
obfuscation
— Seed
obfuscation
Seed Round - Avivo Biomedical Logo
Seed Round - Avivo Biomedical
—
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Contacts 7

Employee Profiles

News

News and Press

News•Jun 2, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 12, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 9, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 6, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

282
156.36%
 in past month

IT Spend

$87.8KThis year, Avivo Biomedical is projected to spend $87.8K on IT, according to Aberdeen.

Active Website Tech Count

23Avivo Biomedical is actively using 23 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  SSL by Default.
Sub-Organizations
Frequently Asked Questions

Where is Avivo Biomedical's headquarters? Avivo Biomedical is located in Vancouver, British Columbia, Canada.Who invested in Avivo Biomedical? Avivo Biomedical has 3 investors including Genome British Columbia and  Innovate BC.When was the last funding round for Avivo Biomedical? Avivo Biomedical closed its last funding round on
obfuscation
from a Seed round.Who are Avivo Biomedical's competitors? Alternatives and possible competitors to Avivo Biomedical may include Cerus, Grifols, and  OrganOx.How much funding has Avivo Biomedical raised to date? Avivo Biomedical has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(0deebd1 1)
|